Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2015.11.006
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2016
Authors
Publisher
Elsevier BV